Inventor · Brookline, MA, US

Gary S. Gray

31Patents
20h-index
30Co-inventors
81Inventor score

Filing activity: Jul 26, 1993 → Mar 2, 2006

Most-cited inventions

PatentTitleAreaCited byStatus
US6352694B1 Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells Chemistry; Metallurgy 442 Expired
US6534055B1 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 388 Expired
US6905680B2 Methods of treating HIV infected subjects Chemistry; Metallurgy 323 Expired
US6887466B2 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 322 Expired
US6905681B1 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 320 Expired
US5858358A Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 299 Expired
US7175843B2 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 286 Expired
US5883223A CD9 antigen peptides and antibodies thereto Chemistry; Metallurgy 285 Expired
US7232566B2 Methods for treating HIV infected subjects Chemistry; Metallurgy 277 Expired
US7144575B2 Methods for selectively stimulating proliferation of T cells Chemistry; Metallurgy 274 Expired
US6444792B1 CTLA4-C&ggr;4 fusion proteins Chemistry; Metallurgy 104 Expired
US7034121B2 Antibodies against CTLA4 Chemistry; Metallurgy 73 Expired
US6719972B1 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies Chemistry; Metallurgy 62 Expired
US6913747B1 Humanized immunoglobulin reactive with B7 therewith Chemistry; Metallurgy 60 Expired
US5942607A B7-2: a CTLA4/CD28 ligand Chemistry; Metallurgy 57 Expired
US5861310A Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor Chemistry; Metallurgy 56 Expired
US6984383B1 Method of transplanting cells by contacting donor cells with B7-1-and B7-2-specific immunoglobulins Chemistry; Metallurgy 50 Expired
US6750334B1 CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor Chemistry; Metallurgy 46 Expired
US6130316A Fusion proteins of novel CTLA4/CD28 ligands and uses therefore Chemistry; Metallurgy 36 Expired
US7479269B2 Methods for selectively enriching TH1 and TH2 cells Chemistry; Metallurgy 21 Active
US6084067A CTLA4/CD28 ligands and uses therefor Chemistry; Metallurgy 18 Expired
US6824779B1 Methods for inhibiting the interaction of B7-2 with its natural ligand Chemistry; Metallurgy 16 Expired
US6605279B2 Therapeutic compositions for inhibiting the interactions of B7-1 and B7-2 with their natural ligands Chemistry; Metallurgy 11 Expired
US6827934B1 Humanized immunoglobulin reactive with b7-2 and methods of treatment therewith Chemistry; Metallurgy 8 Expired
US6972125B2 Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith Chemistry; Metallurgy 3 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.